Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Shepherd

Showing results (241-250 of 256) with videos related to

Pageof 26
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 31, 2016
Mortality According to CD4 Count at Start of Combination Antiretroviral Therapy Among HIV-infected Patients Followed for up to 15 Years After Start of Treatment: Collaborative Cohort StudyMargaret T May, Jorg-Janne Vehreschild, Adam Trickey, et al.
Nature|January 14, 2026
Retraction Note: Antibodies against endogenous retroviruses promote lung cancer immunotherapyKevin W Ng, Jesse Boumelha, Katey S S Enfield, et al.
Nature|April 12, 2023
Antibodies against endogenous retroviruses promote lung cancer immunotherapyKevin W Ng, Jesse Boumelha, Katey S S Enfield, et al.
Cancer Cell|October 29, 2021
Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinomaLewis Au, Emine Hatipoglu, Marc Robert de Massy, et al.
Lancet (London, England)|January 29, 2022
Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancerAnnika Fendler, Scott T C Shepherd, Lewis Au, et al.
Cell Reports. Medicine|October 14, 2022
Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancerAnnika Fendler, Scott T C Shepherd, Lewis Au, et al.
Cancer Cell|April 12, 2022
Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancerAnnika Fendler, Scott T C Shepherd, Lewis Au, et al.
Cancer Cell|April 28, 2023
Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancerMary Y Wu, Scott T C Shepherd, Annika Fendler, et al.
Cancer Cell|December 30, 2021
Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancerAnnika Fendler, Scott T C Shepherd, Lewis Au, et al.
Cancer Discovery|March 28, 2023
Late-Stage Metastatic Melanoma Emerges through a Diversity of Evolutionary PathwaysLavinia Spain, Alexander Coulton, Irene Lobon, et al.
Pageof 26

Showing results (241-250 of 256) with videos related to

Sort By:
Pageof 26
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 31, 2016
Mortality According to CD4 Count at Start of Combination Antiretroviral Therapy Among HIV-infected Patients Followed for up to 15 Years After Start of Treatment: Collaborative Cohort StudyMargaret T May, Jorg-Janne Vehreschild, Adam Trickey, et al.
Nature|January 14, 2026
Retraction Note: Antibodies against endogenous retroviruses promote lung cancer immunotherapyKevin W Ng, Jesse Boumelha, Katey S S Enfield, et al.
Nature|April 12, 2023
Antibodies against endogenous retroviruses promote lung cancer immunotherapyKevin W Ng, Jesse Boumelha, Katey S S Enfield, et al.
Cancer Cell|October 29, 2021
Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinomaLewis Au, Emine Hatipoglu, Marc Robert de Massy, et al.
Lancet (London, England)|January 29, 2022
Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancerAnnika Fendler, Scott T C Shepherd, Lewis Au, et al.
Cell Reports. Medicine|October 14, 2022
Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancerAnnika Fendler, Scott T C Shepherd, Lewis Au, et al.
Cancer Cell|April 12, 2022
Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancerAnnika Fendler, Scott T C Shepherd, Lewis Au, et al.
Cancer Cell|April 28, 2023
Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancerMary Y Wu, Scott T C Shepherd, Annika Fendler, et al.
Cancer Cell|December 30, 2021
Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancerAnnika Fendler, Scott T C Shepherd, Lewis Au, et al.
Cancer Discovery|March 28, 2023
Late-Stage Metastatic Melanoma Emerges through a Diversity of Evolutionary PathwaysLavinia Spain, Alexander Coulton, Irene Lobon, et al.
Pageof 26